David M. Foureau, PhD of Levine Cancer Institute discusses how targeting T-cells in myeloma may be the new focus for clinical trials at the 58th ASH Annual Meeting in San Diego, CA.
Targeting T-Cells in Multiple Myeloma May Be Focus For New Clinical Trials
